Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature

Kidney International

Volumn 56, Issue 2, 1999, Pages 509-516

  Tsuchida, Shinya ^a   Miyazaki, Yoichi ^a   Matsusaka, Taiji ^a   Hunley, Tracy E ^a   Inagami, Tadashi ^a   Fogo, Agnes ^a   Ichikawa, Iekuni ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bradykinin; Kinase II; Kinin kallikrein system; Renin angiotensin system; Vascular hypertrophy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; APROTININ; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ICATIBANT; KALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; ENZYME REPRESSION; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; KALLIKREIN KININ SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RENOVASCULAR DISEASE; THICKNESS;

EID: 0032810618     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00574.x     Document Type: Article

References (32)

1. 1. KAKINUMA Y, FOGO A, INAGAMI T, ICHIKAWA I: Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat. Kidney Int 43:1229-1235, 1993
2. 2. NIIMURA F, OKUBO S, FOGO A, ICHIKAWA I: Temporal and spatial expression pattern of the angiotensinogen gene in mice and rats. Am J Physiol 272:R142-RI47, 1997
3. 3. JUNG FF, BOUYOUNES B, BARRIO R, TANG SS, DIAMANT D, INGELFINGER JR: Angiotensin converting enzyme in renal ontogeny: Hypothesis for multiple roles. Ped Nephrol 7:834-840, 1993
4. 4. TSUCHIDA S, MATSUSAKA T, CHEN X, OKUBO S, NIIMURA F, NISHIMURA H, FOGO A, UTSUNOMIYA H, INAGAMI T, ICHIKAWA I: Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101:755-760, 1998
5. 5. KIM HS, KREGE JH, KLUCKMAN KD, HAGAMAN JR, HODGIN JB, BEST CF, JENNETTE JC, COFFMAN TM, MAEDA N, SMITHIES O: Genetic control of blood pressure and the angiotensinogen locus. Proc Nat Acad Sci USA 92:2735-2739, 1995
6. 6. NIIMURA F, LABOSKY PA, KAKUCHI J, OKUBO S, YOSHIDA H, OIKAWA T, ICHIKI T, NAFTILAN AJ, FOGO A, INAGAMI T, ICHIKAWA I: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96:2947-2954, 1995
7. 7. KREGE JH, JOHN SW, LANGENBACH LL, HODGIN JB, HAGAMAN JR, BACHMAN ES, JENNETTE JC, O'BRIEN DA, SMITHIES O: Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148, 1995
8. 8. ESTHER CR JR, HOWARD TE, MARINO EM, GODDARD JM, CAPECCHI MR, BERNSTEIN KE: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74:953-965, 1996
9. 9. MATSUSAKA T, HYMES J, ICHIKAWA I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 7:2025-2043, 1996
10. 10. KON V, FOGO A, ICHIKAWA I: Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int 44:545-550, 1993
11. 11. BHOOLA KD, FIGUEROA CD, WORTHY K: Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol Rev 44:1-80, 1992
12. 12. EL-DAHR SS, DIPP S, YOSIPIV IV, BARICOS WH: Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cells. Kidney Int 50:1850-1855, 1996
13. 13. DIXON BS, DENNIS MJ: Interaction of kinins and captopril in regulating arterial smooth muscle cell proliferation. Kidney Int 61(Suppl):S14-S17, 1997
14. 14. FIGUEROA CD, GONZALEZ CB, GRIGORIEV S, ABD ALLA SA, HAASEMANN M, JARNAGIN K, MULLER-ESTERL W: Probing for the bradykinin B2 receptor in rat kidney by anti-peptide and anti-ligand anti-bodies. J Histochem Cytochem 43:137-148, 1995
15. 15. MATSUSAKA T, NISHIMURA H, UTSUNOMIYA H, KAKUCHI J, NIIMURA F, INAGAMI T, FOGO A, ICHIKAWA I: Chimeric mice carrying 'regional' targeted deletion of the angiotensin type IA receptor gene. Evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J Clin Invest 98:1867-1877, 1996
16. 16. GOBEIL F, NEUGEBAUER W, FILTEAU C, JUKEC D, ALLOGHO SN, PHENG LH, NGUYEN-LE XK, BLOUIN D, REGOLI D: Structure-activity studies of B1 receptor-related peptides. Antagonists. Hypertension 28:833-839, 1996
17. 17. MADEDDU P, VARONI MV, PALOMBA D, EMANUELI C, DEMONTIS MP, GLORIOSO N, DESSI-FULGHERT P, SARZANI R, ANANIA V: Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96:3570-3578, 1997
18. 18. MADEDDU P, PARPAGLA PP, DEMONTIS MP, VARONI MV, FATTACCIO MC, ANANIA V, GLORIOSO N: Early blockade of bradykinin B2-receptors alters the adult cardiovascular phenotype in rats. Hypertension 25:453-459, 1995
19. 19. WANG J, XIONG W, YANG Z, DAVIS T, DEWEY MJ, CHAO J, CHAO L: Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 23:236-243, 1994
20. 20. MAJIMA M, YOSHIDA O, MIHARA H, MURO T, MIZOGAMI S, KURIBAYASHI Y, KATORI M, OH-ISHI S: High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats. Hypertension 22:705-714, 1993
21. 21. MENG QC, BALCELLS E, DELLITALIA L, DURAND J, OPARII S: Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue. Biochem Pharmacol 50:1445-1450, 1995
22. 22. LOWRY O, ROSEBBROUGH N, FARR A, RANDAL R: Protein measurement with the Folin phenolreagent. J Biol Chem 193:265-275, 1951
23. 23. CHEN X, LI W, YOSHIDA H, TSUCHIDA S, NISHIMURA H, TAKEMOTO F, OKUBO S, FOGO A, MATSUSAKA T, ICHIKAWA I: Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol 272:F299-F304, 1997
24. 24. VAN LEEUWEN BH, EVANS BA, TREGEAR GW, RICHARDS RI: Mouse glandular kallikrein genes. Identification, structure, and expression of the renal kallikrein gene. J Biol Chem 261:5529-5535, 1986
25. 25. KOIKE, G, KRIEGER JE, JACOB HJ, MUKOYAMA M, PRATT RE, DZAU VJ: Angiotensin converting enzyme and genetic hypertension: Cloning of rat cDNAs and characterization of the enzyme. Biochem Biophy Res Com 198:380-386, 1994
26. 26. MIYAZAKI Y, TSUCHIDA S, FOGO A, ICHIKAWA I: The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney Int 55:1683-1695, 1999
27. 27. FARHY RD, CARRETERO OA, HO KL, SCICLI AG: Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 72:1202-1210, 1993
28. 28. DIXON BS, DENNIS MJ: Regulation of mitogenesis by kinins in arterial smooth muscle cells. Am J Physiol 273:C7-C20, 1997
29. 29. DIXON BS, SHARMA RV, DENNIS MJ: The bradykinin B2 receptor is a delayed early response gene for platelet-derived growth factor in arterial smooth muscle cells. J Biol Chem 271:13324-13332, 1996
30. 30. PRUNEAU D, BELICHARD P: Induction of bradykinin B1 receptor-mediated relaxation in the isolated rabbit carotid artery. Eur J Pharmacol 239:63-67, 1993
31. 31. PRUNEAU D, LUCCARINI JM, ROBERT C, BELICHARD P: Induction of kinin B1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery. Br J Pharmacol 111:1029-1034, 1994
32. 32. HUMES HD, BEALS TF, CIESLINSKI DA, SANCHEZ IO, PAGE TP: Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells. Lab Invest 64:538-545, 1991